XML 47 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
Reverse Recapitalization - Summary of Number of Common Shares Outstanding (Details) - shares
Jan. 31, 2024
Oct. 31, 2023
Reverse Recapitalization [Line Items]    
Total Common Shares outstanding immediately after the Reverse Recapitalization and PIPE Financing 23,197,976 23,197,976
Old enGene Shareholders (Excluding Convertible Notes)    
Reverse Recapitalization [Line Items]    
Total Common Shares outstanding immediately after the Reverse Recapitalization and PIPE Financing 6,711,786  
FEAC Shareholders, including sponsor's and shareholder with non-redemption agreement    
Reverse Recapitalization [Line Items]    
Total Common Shares outstanding immediately after the Reverse Recapitalization and PIPE Financing 3,670,927  
Convertible Notes - Common Shares Issued    
Reverse Recapitalization [Line Items]    
Total Common Shares outstanding immediately after the Reverse Recapitalization and PIPE Financing 6,379,822  
Common Shares Issued to Pipe Investors    
Reverse Recapitalization [Line Items]    
Total Common Shares outstanding immediately after the Reverse Recapitalization and PIPE Financing 6,435,441